Stay updated on Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial

Sign up to get notified when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:46:23.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now identifies the release as v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T22:28:28.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T22:26:45.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the usual study details. This blocks access to core study information and related content on the page.
    Difference
    20%
    Check dated 2026-09-20T20:03:49.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6 instead of Revision: v3.6.5, reflecting a small platform or document revision that typically does not alter study details or user-facing information.
    Difference
    0.0%
    Check dated 2026-08-30T22:00:42.000Z thumbnail image
  6. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was added (replacing v3.6.4). This indicates a behind-the-scenes update with no changes to the study details or page content.
    Difference
    0.0%
    Check dated 2026-08-09T10:54:37.000Z thumbnail image

Stay in the know with updates to Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.